Over the last few decades, our understanding of clinical and pathological differences in GBA1-PD and LRRK2-PD has greatly increased; however, the issue of identifying those at greatest risk of conversion to PD remains beyond our capabilities. The gene discussed is LRRK2; the disease is Parkinson disease.